Although our results confirm that the coagulation score is relevant to the prognosis of bladder cancer and the therapeutic efficacy of PD1/PDL1, further studies are needed to confirm the clinical utility of the coagulation score and its utility as a useful biomarker. Here, CD274 is linked to urinary bladder carcinoma.